相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endothelial cellmetabolicmemory causes cardiovascular dysfunction in diabetes
Yufeng Yao et al.
CARDIOVASCULAR RESEARCH (2022)
Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis
Kai Jiang et al.
PROTEIN & CELL (2022)
Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms
Gianluigi Savarese et al.
CARDIOVASCULAR RESEARCH (2022)
Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture
Rama Natarajan
DIABETES (2021)
Association of CX3CR1 Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure
Lukasz Wozny et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Impaired brain fractalkine-CX3CR1 signaling is implicated in cognitive dysfunction in diet-induced obese mice
Namiko Kawamura et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
Sibylle von Vietinghoff et al.
CELL AND TISSUE RESEARCH (2021)
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline
Sheyu Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
Emily Brown et al.
LANCET (2021)
Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways
Nami Lee et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
Felipe A. Martinez et al.
CIRCULATION (2020)
Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat
Sin-Hee Park et al.
CARDIOVASCULAR DIABETOLOGY (2020)
p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease
Zhengwei Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
David C Wheeler et al.
Lancet Diabetes & Endocrinology (2020)
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies A Scientific Statement From the American Heart Association
Janani Rangaswami et al.
CIRCULATION (2019)
Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function
Matthew Riopel et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis
Junlian Gu et al.
CELL DEATH & DISEASE (2018)
Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice
Juha Gronholm et al.
DIABETOLOGIA (2017)
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
Aramesh Saremi et al.
DIABETES CARE (2017)
Thinking bedside at the bench: the NOD mouse model of T1DM
James C. Reed et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Secreted frizzled-related protein 4 (SFRP4) and fractalkine (CX3CL1) - Potential new biomarkers for β-cell dysfunction and diabetes
Katarzyna Bergmann et al.
CLINICAL BIOCHEMISTRY (2014)
The Fractalkine/CX3CR1 System Regulates β Cell Function and Insulin Secretion
Yun Sok Lee et al.
CELL (2013)
Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice
K. H. Song et al.
DIABETOLOGIA (2013)
Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine
Wanling Xuan et al.
CRITICAL CARE MEDICINE (2012)
Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy
Bing Li et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fractalkine is an independent predictor of mortality in patients with advanced heart failure
Bernhard Richter et al.
THROMBOSIS AND HAEMOSTASIS (2012)
The emerging challenge in diabetes: The metabolic memory
Antonio Ceriello
VASCULAR PHARMACOLOGY (2012)
Intermedin induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton: role of RhoA and Rac1
Muhammad Aslam et al.
CARDIOVASCULAR RESEARCH (2011)
Detrimental effect of fractalkine on myocardial ischaemia and heart failure
Wanling Xuan et al.
CARDIOVASCULAR RESEARCH (2011)
Mitochondrial Oxidative Stress Mediates Angiotensin II-Induced Cardiac Hypertrophy and Gαq Overexpression-Induced Heart Failure
Dao-Fu Dai et al.
CIRCULATION RESEARCH (2011)
TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model
Yun Ti et al.
DIABETES (2011)
Fractalkine Is a Novel Human Adipochemokine Associated With Type 2 Diabetes
Rachana Shah et al.
DIABETES (2011)
Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes
Munehiro Kitada et al.
EXPERIMENTAL DIABETES RESEARCH (2011)
Fractalkine in human inflammatory cardiomyopathy
F. Escher et al.
HEART (2011)
Transcriptional and posttranscriptional regulators of biglycan in cardiac fibroblasts
Karen Tiede et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction
Marcin Dobaczewski et al.
CIRCULATION RESEARCH (2010)
The cardiorenal syndrome in diabetes mellitus
Hussein H. Karnib et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice
Jianjian Shi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
Youhua Liu
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure
Michael J. Koziolek et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Fractalkine-Induced Endothelial Cell Migration Requires MAP Kinase Signaling
Michael V. Volin et al.
PATHOBIOLOGY (2010)
Model of Excitation-Contraction Coupling of Rat Neonatal Ventricular Myocytes
Topi Korhonen et al.
BIOPHYSICAL JOURNAL (2009)
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure
Cathrine Husberg et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice
Dong-Jin Oh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Apoptosis in patients with dilated cardiornyopathy and diabetes: A feature of diabetic cardiomyopathy?
F. Kuethe et al.
HORMONE AND METABOLIC RESEARCH (2007)
Hypothesis: the 'metabolic memory', the new challenge of diabetes
M. A. Ihnat et al.
DIABETIC MEDICINE (2007)
RhoA/Rho kinase up-regulate bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis
Dominic P. Del Re et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Wnt/β-catenin signaling modulates survival of high glucose-stressed mesangial cells
Chun-Liang Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis
Jiang Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress
Stefano Menini et al.
DIABETES (2006)
Fractalkine in vascular biology - From basic research to clinical disease
H Umehara et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model
YL Liao et al.
CIRCULATION RESEARCH (2003)
Glucagon-like peptide-1 and exendin-4 stimulate β-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age
C Tourrel et al.
DIABETES (2001)
分享论文
